Buy Immuno-oncology and Immunotherapy Part F by Lorenzo Galluzzi
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Home > Mathematics and Science Textbooks > Biology, life sciences > Molecular biology > Immuno-oncology and Immunotherapy Part F: Volume 201(Volume 201 Methods in Cell Biology)
Immuno-oncology and Immunotherapy Part F: Volume 201(Volume 201 Methods in Cell Biology)

Immuno-oncology and Immunotherapy Part F: Volume 201(Volume 201 Methods in Cell Biology)


     0     
5
4
3
2
1



Out of Stock


Notify me when this book is in stock
X
About the Book

Radiation Oncology and Radiotherapy Part B, Volume 174 of Methods in Biology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

Table of Contents:
1. Generation and functional evaluation of STAb-T cells Luis Alvarez-Vallina 2. A syngeneic orthotopic mouse model of metastatic colorectal cancer Christel Devaud 3. High-parameter T-cell spectral phospho flow cytometry Joshua Brody and Gvantsa Pantsulaia 4. Measuring T-cell/CAR T-cell bystander tumor killing in vitro and in vivo Joshua Brody, Matthew Lin and Daniel Charytonowicz 5. Quantification and functional assessment of antigen(-) cancer cell variants Joshua Brody, Gvantsa Pantsulaia, Ivan Odak and Xie Xinping 6. T-cell and CAR T-cell Cas9-RNP/nucleofection-mediated gene editing Joshua Brody, Gvantsa Pantsulaia and Moah Sohn 7. Peripheral blood mononuclear cell (PBMC)- based functional evaluation of human T cell response to suppressive cells and immune-oncology therapeutics Maria G. Castro, Kaushik Banerjee, Pedro R. Lowenstein, Mahmoud Alghamri, Brandon McClellan and Jorge Peña Agudelo 8. Integrative analysis of lung multiparametric flow cytometry data to study immune cell dynamics in tumors Romina Goldszmid and Romina Araya 9. Multiparametric staining: Combined application of immunofluorescence and in-situ hybridization Barbara Seliger, Marcus Bauer, Andreas Wilfer, Clara Zöllig and Claudia Wickenhauser 10. Extracellular matrix and morphology assessment method on live 3D spheroids of thyroid carcinoma Barbara Seliger, Mario Udinotti, Udo Sieboldts and Christoforos Vaxevanis 11. Hema-CRISPR: A clone-based protocol for effective genetic editing of hematopoietic stem cells Barbara Seliger, Christoforos Vaxevanis, Mario Udinotti, Dimitris Kokoretsis, Andreas Wilfer, Marcus Bauer and Claudia Wickenhauser 12. Patient-derived models of tumor-immune cell interactions Zlatko Trajanoski 13. MDSC isolation from human tumors Viktor Umansky, Feyza Gul Ozbay Kurt and Jochen Utikal 14. Extracellular vesicles isolation from human maternal fluids Sheila Spada 15. Finding a Needle in a Haystack: Measures of Circulating Tumor DNA (ctDNA) to Guide Treatment Decisions in Oncology Lotze, Michael T, Genia Dubrovsky, Jeff Szymanski, Aadel A. Chaudhuri, Jose Zevallos, Noah Earland, Peter Harris and Pradeep Chauhan

About the Author :
Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology. Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience. Norma received her master’s degree in health biology from Paris Saclay. In 2013, she joined the laboratory of Dr. Guido Kroemer at the Centre de Recherche des Cordeliers (Paris, France) and at Gustave Roussy (Villejuif, France), the largest center for oncological patients in Europe. She worked on several projects linked to immunosurveillance, culminating with her obtaining her PhD in 2017 with an original work on “Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance”. She then moved to Weill Cornell Medicine to join the program in radiation and immunity under the mentorship of Dr. Galluzzi. Her current research is focused on investigating resistance to immunotherapy in a mouse model of HR+ breast cancer. Maud Charpentier received her M.Sc. in Cellular Biology and her Ph.D. in Immunology from the University of Nantes, France. She chose to pursue an academic career and continued her postdoctoral training in the United States. She joined the Department of Radiation Oncology at Weill Cornell Medicine under the mentorship of Dr. Sandra Demaria. Maud has a long-standing interest in the anti-tumor immune response and its role in controlling cancer progression and treatment outcomes. Her research focuses on understanding the synergy between radiation therapy and immunotherapy in solid tumors, with the aim of overcoming resistance to treatment and developing innovative therapeutic approaches in preclinical models. Jose Manuel Bravo-San Pedro is currently a researcher at the Department of Physiology of the Complutense University of Madrid thanks to a Ramon y Cajal contract grant. He got his Ph.D. in biochemistry, cellular biology and genetics from the University of Extremadura (Caceres, Spain) in 2011, and he did a post-doctoral stage in the laboratory of Prof. Guido Kroemer. His main research interests have always been linked to autophagy, addressing this cellular process associated with neurodegenerative diseases or cancer and recently obesity and specifically related to problems in the correct functioning of the cilium. He is co-inventor of two patents and co-author of 110 publications indexed in PubMed in prestigious international journals, with h-index 45 and 23768 cites (Dec 2022).


Best Sellers


Product Details
  • ISBN-13: 9780443296147
  • Publisher: Elsevier Science Publishing Co Inc
  • Publisher Imprint: Academic Press Inc
  • Height: 229 mm
  • No of Pages: 318
  • Sub Title: Volume 201
  • ISBN-10: 0443296146
  • Publisher Date: 15 Jan 2026
  • Binding: Hardback
  • Language: English
  • Series Title: Volume 201 Methods in Cell Biology
  • Width: 152 mm


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Immuno-oncology and Immunotherapy Part F: Volume 201(Volume 201 Methods in Cell Biology)
Elsevier Science Publishing Co Inc -
Immuno-oncology and Immunotherapy Part F: Volume 201(Volume 201 Methods in Cell Biology)
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Immuno-oncology and Immunotherapy Part F: Volume 201(Volume 201 Methods in Cell Biology)

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    Fresh on the Shelf


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!